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Introduction: Induced pluripotent stem cells (iPSCs) have emerged as a promising cell source for immune-compatible
cell therapy. Although a variety of somatic cells have been tried for iPSC generation, it is still of great interest to test
new cell types, especially those which are hardly obtainable in a normal situation.
Methods: In this study, we generated iPSCs by using the cells originated from intervertebral disc which were removed
during a spinal operation after spinal cord injury. We investigated the pluripotency of disc cell-derived iPSCs (diPSCs)
and neural differentiation capability as well as therapeutic effect in spinal cord injury.
Results: The diPSCs displayed similar characteristics to human embryonic stem cells and were efficiently differentiated
into neural precursor cells (NPCs) with the capability of differentiation into mature neurons in vitro.
When the diPSC-derived NPCs were transplanted into mice 9 days after spinal cord injury, we detected a significant
amelioration of hindlimb dysfunction during follow-up recovery periods. Histological analysis at 5 weeks after
transplantation identified undifferentiated human NPCs (Nestin+) as well as early (Tuj1+) and mature (MAP2+)
neurons derived from the transplanted NPCs. Furthermore, NPC transplantation demonstrated a preventive effect
on spinal cord degeneration resulting from the secondary injury.
Conclusion: This study revealed that intervertebral discs removed during surgery for spinal stabilization after
spinal cord injury, previously considered a “waste” tissue, may provide a unique opportunity to study iPSCs
derived from difficult-to-access somatic cells and a useful therapeutic resource for autologous cell replacement
therapy in spinal cord injury.Introduction
The advent of induced pluripotent stem cells (iPSCs)
opened a new avenue for immune-compatible cell replace-
ment therapy as well as in vitro disease modeling, drug
discovery, and toxicity testing [1–4]. Until now, most
iPSCs have been generated by using fibroblasts [5], ker-
atinocytes [6], adipose-derived stromal cells [7], and
peripheral blood cells [8–10]; however, obtaining somatic
cells requires additional painful sampling procedures for* Correspondence: hayoon@yuhs.ac; hdy@cha.ac.kr
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article, unless otherwise stated.patients already suffering from unexpected and sudden
trauma such as spinal cord injury (SCI). Therefore, it
would be convenient and practical to use tissues removed
during emergency surgery after SCI to generate iPSCs for
autologous cell replacement therapy.
SCI is caused by spine fracture often resulting from a
sports injury, traffic accident, or fall. In any case, the
fractured spinal vertebra and intervertebral disc are to
be removed by spinal stabilization surgery. Therefore,
the dissected tissues may be a useful source for iPSC
generation. Furthermore, the tissues and cell types ob-
tained in this case are difficult to achieve with a normal
biopsy, providing a unique opportunity for evaluating
these cell types as a source for iPSC generation.
Cell therapy using human pluripotent stem cells (hPSCs),
such as human embryonic stem cells (hESCs) and iPSCs, isdistributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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Several reports confirmed the efficacy of hPSC transplant-
ation using animal models of SCI [11].
In this study, we sought to generate iPSCs by using
human intervertebral disc cells removed during surgery
on patients with SCI. This study reported the first gen-
eration of hiPSCs from human intervertebral discs and
provided a good example of harnessing “waste” surgical
tissue to generate iPSCs for future autologous stem cell
therapy for SCI.
Methods
Isolation of human disc cells
This study was approved by the Institutional Review
Board of Yonsei University. We received all necessary
consent from any patients for the use for their tissue
samples for the purpose of this study. Dissected disc
tissue was washed with 1× phosphate-buffered saline
(1×PBS) (Wellgene, Daegu, Korea) and then incubated
with collagenase A (Roche, Mannheim, Germany) for 4 h
with shaking every hour. The enzyme-treated tissue was
filtered through 100-μm mesh (BD Biosciences, Billerica,
MA, USA), washed three times with 1×PBS, and finally
resuspended in Dulbecco’s modified Eagle’s medium
(DMEM)/F12 (Invitrogen, Carlsbad, CA, USA) supple-
mented with 10 % fetal bovine serum (FBS) (Hyclone,
Logan, UT, USA) and 1 % penicillin/streptomycin (P/S)
(Invitrogen) for incubation in a humidified chamber
(37 °C, 5 % CO2).
Production of retroviruses
Twenty-four hours before transfection, 293T cells
(ATCC, Manassas, VA, USA) were seeded onto 10-cm
culture dishes (BD Biosciences) at a density of 5×104
cells/cm2 and cultured overnight in an incubator (37 °C,
5 % CO2). For transfection, 3 μg each of four recombin-
ant Moloney-based retroviral vectors (pMXs; Addgene,
Cambridge, MA, USA) expressing human octamer-
binding transcription factor 4 (Oct4), SRY (sex determin-
ing region)-box 2 (Sox2), Kruppel-like factor 4 (Klf4),
and c-Myc genes, 2 μg of pGag/Pol (Addgene), and 1 μg
of pVSV-G (Addgene) were mixed with Convoy™ Trans-
fection Reagent (ACTGene, Piscataway, NJ, USA) and
added to cells of approximately 80–90 % confluence,
following the suggestions of the manufacturer. Medium
was changed the next morning and collected 2 days
later, followed by ultracentrifugation (64,000×g, 4 °C,
90 min) for harvesting viruses. Viruses in the pellet
were resuspended in 0.1 ml of 1×PBS and used for
transduction.
Generation of induced pluripotent stem cells
Disc cells (approximately 5×104) were seeded in a six-
well plate (Thermo Scientific, Hudson, NH, USA) with3 ml of medium consisting of DMEM, 10 % FBS, and 1 %
P/S (all from Invitrogen). After approximately 8–12 h, the
disc cells were treated with the retroviral solution with
addition of protamine sulfate (5 μg/ml) (Sigma-Aldrich,
St. Louis, MO, USA) and subjected to further incubation
for 14–16 h. The next day, the cells were washed three
times with 1×PBS (Welgene, Gyeongsangbuk-do, Korea),
and 3 ml of fresh medium was added. Five days after viral
transduction, the disc cells were transferred into 6-cm
vitronectin-coated dishes (BD Biosciences) at a density of
1–3×104 cells per dish and were cultured two more days
in the disc cell culture medium, followed by further incu-
bation with daily change of the extracelluar matrix-based
hPSC medium, as previously established [12]. ESC-like
colonies were selected as a clone at approximately 20–25
days and were subjected to expansion.
Immunocytochemistry
Samples were washed three times with 1×PBS and then
fixed for 10 min with 4 % paraformaldehyde (PFA)
(Merck, Darmstadt, Germany)/1×PBS. After being
washed with 1×PBS three times for 10 min each, the
samples were treated with a blocking solution (10 % nor-
mal donkey serum/1×PBS) (Jackson ImmunoResearch,
West Grove, PA, USA) for 1 h at room temperature
(RT). The samples were subjected to consecutive
treatments with primary and secondary antibodies for
1 h each at RT. The samples were treated with DAPI
(4′,6-diamidino-2-phenylindole) (Vector Laboratories,
Peterborough, UK) for 5 min after the secondary
antibody treatments.
The primary antibodies used in this study are shown in
Additional file 1. The secondary antibodies used in this study
include an Alexa Fluor 594 goat anti-mouse IgG (1:500),
fluorescein isothiocyanate (FITC) donkey anti-mouse IgG
(1:500), Cy3 donkey anti-rabbit IgG (1:500), FITC donkey
anti-rabbit IgG (1:500), and FITC donkey anti-chicken IgY
(1:500) (all from Jackson ImmunoResearch).
Alkaline phosphatase staining
Human iPSCs were stained for alkaline phosphatase by
using the Alkaline Phosphatase Detection Kit (Sigma-
Aldrich) in accordance with the instructions of the
manufacturer.
Reverse transcription-polymerase chain reaction
The total RNA samples were prepared by using a
NucleoSpin RNA II kit (Macherey-Nagel GmbH, Dueren,
Germany) in accordance with the instructions of the
manufacturer. One microgram of total RNA was used to
generate cDNAs by using a ReverTra Ace quantitative re-
verse transcription-polymerase chain reaction (qRT-PCR)
Kit (Toyobo, Osaka, Japan). PCR was performed by using
an Eppendorf Master cycler gradient (Eppendorf,
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°C denaturation for 2 min, (2) 95 °C denaturation for 40
seconds, (3) 55–63 °C annealing for 30 seconds, and (4)
72 °C polymerization for 1–2 min. Steps (2)–(4) were
repeated for 20–35 cycles, depending on the target
cDNA, followed by a final polymerization step at 72 °C
for 10 min. Primer information used in this study is
shown in Additional file 2.DNA microarray analysis
Total RNA was isolated by using a NucleoSpin RNA II Kit
in accordance with the suggestions of the manufacturer,
and 2 μg of total RNA was used for a genome-wide gene
expression profiling experiment by using the Illumina array
(Illumina, San Diego, CA, USA) at Macrogen (Macrogen,
Seoul, Korea). Microarray data were deposited in a public
repository such as gene expression omnibus (series record
GSE64964).DNA methylation analysis
The genomic DNA samples were prepared by using a
DNeasy Tissue Kit (Qiagen, Hilden, Germany) in ac-
cordance with the instructions of the manufacturer.
DNA (2 μg) was treated with an EpiTect Bisulfite Kit
(Qiagen) following the instructions of the manufacturer.
The promoter areas of the Oct4 and Nanog genes were
amplified by PCR, subcloned into a TA cloning vector
(RBC Bioscience, New Taipei City, Taiwan), and sub-
jected to sequencing analysis.Pluripotency test in vitro
For the in vitro examination of pluripotency, both hESCs
and iPSCs were mechanically detached from the plate
and cultured in a Petri dish (SPL Life Sciences, Pocheon,
Korea) by using the embryoid body (EB) medium
(DMEM/F12), 10 % Knockout SR, 1 % non-essential
amino acid (NEAA), 0.1 mM β-mercapto ethanol, and 1 %
P/S (all from Invitrogen) for 15 days. EBs were attached to
Matrigel (BD Biosciences)-coated slides, and EBs were im-
munostained for representative markers (Additional file 1)
of the three germ layers.Teratoma formation
For teratoma assay, hPSC colonies were mechanically
detached and injected into the testes and muscle of a
non-obese diabetic/severe combined immunodeficiency
(NOD/SCID) (Orient bio, Gyeonggido, Korea) mouse.
Roughly 2×106 hPSCs from a 6-cm dish (BD Biosciences)
were injected into a NOD/SCID mouse. The teratomas
were dissected 8–10 weeks later and were subjected to
hematoxylin-and-eosin (Sigma-Aldrich) staining for histo-
logical analysis.G-banding analysis
A G-banding karyotype analysis of hESCs and iPSCs was
performed in the Sam Kwang Medical Laboratories
(Smlab, Seoul, Korea). Cells were treated with 0.03 mg/ml
KaryoMAX Colcemid Solution (Invitrogen) overnight and
were followed by treating with 0.05 % trypsin (Invitrogen)
for 5 min at 37 °C. The trypsin was inactivated by adding
DMEM containing 10 % FBS. Pre-warmed hypotonic solu-
tion containing equal amounts of 0.4 % potassium chlor-
ide (Sigma-Aldrich) and 0.4 % sodium citrate (Sigma-
Aldrich) was slowly added to the cells to enhance swelling.
Carnoy’s solution (methanol:glacial acetic acid, 3:1) was
used to fix the cells for 30 min at RT. The cells were then
dropped onto a pre-cleaned slide, and the metaphase
spread quality was determined by using a phase-contrast
microscope. The slide was hybridized with probes from
the SkyPaint DNA Kit (Applied Spectral Imaging, Vista,
CA, USA) for human chromosomes for 2 days in a 37 °C
humidified chamber. The finished metaphase spreads
were visualized and analyzed by using the SkyView spec-
tral imaging system (Applied Spectral Imaging).
DNA fingerprinting analysis
We performed DNA fingerprinting analyses at the DNA
Sequencing Core Facility of Korea Gene Information
Center (Seoul, Korea). To verify the genetic relatedness of
the iPSC lines to their parent fibroblasts, PCR amplifica-
tion was performed across discrete genomic regions con-
taining highly variable numbers of tandem repeats. The
amplified DNAs were compared by sequencing analysis.
Induction and culture of neural progenitor cells
For passaging, disc cell-derived induced pluripotent stem
cell (diPSC) colonies were mechanically dissected into
small fragments with subsequent treatment with 2 mg/ml
of collagenase IV (Invitrogen) for 30–60 min. The colony
fragments were transferred to a 15-ml tube (BD Biosci-
ences), collected at the bottom of the tube by gravity, re-
suspended in 1–2 ml of fresh medium, and seeded into an
uncoated, 6-cm bacterial Petri dish (SPL Life Sciences).
Approximately 200 colony fragments were seeded on a 6-
cm bacterial Petri dish. The colony fragments were cul-
tured in suspension for 4 days in the EB medium
(DMEM/F12, 10 % Knockout SR, 1 % NEAA, 0.1 mM β-
mercapto ethanol, and 1 % P/S; all from Invitrogen) and
were supplemented with dorsomorphin (5 μM) (Sigma-
Aldrich) and SB431542 (10 μM) (Tocris, Bristol, UK).
Fifty to sixty EBs were transferred to a 3-cm
Matrigel-coated dish and were cultured for 6 days in
neural progenitor (NP) selection medium (DMEM/F12,
1 mM L-Glutamine, 1 % NEAA, 0.1 mM β-mercapto
ethanol, 0.5 % N2 supplement, and 20 ng/ml basic
fibroblast growth factor (bFGF); CHA Meditech, Seoul,
Korea) with medium change every 2 days.
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glass pipette (World Precision Instruments, Sarasota, FL,
USA) and cultured in 6-cm Matrigel-coated dishes
containing NP expansion medium (DMEM/F12, 1 mM
L-Glutamine, 1 % NEAA, 0.1 mM β-mercapto ethanol,
0.5 % N2 supplement, 2 % B27 supplement, and 20 ng/ml
bFGF). When the transferred rosettes covered approxi-
mately 90 % of the dishes, they were treated with Accutase
(Invitrogen) for passaging.
Neuronal differentiation
For neuronal differentiation, the iPSC-neural precursor
cells (iPSC-NPCs) were plated at 2×104 cells/cm2 on a
12-mm, round, poly-L-ornithine (20 μg/ml)/laminin
(10 μg/ml) (all from Sigma-Aldrich)-coated glass cover
slip. Cells were maintained in neurobasal medium con-
taining 1 % P/S, 1×Glutamax, 1 % N2, 2 % B27 supple-
ment, 1 % FBS, brain-derived neurotrophic factor (BDNF)
(10 ng/ml) (Peprotech, Rocky Hill, NJ, USA), and glial cell-
derived neurotrophic factor (GDNF) (10 ng/ml) (Pepro-
tech) for 21 days. Half of the medium was replaced every
two days.
Whole-cell patch clamp
The cover slip with cultured cells was transferred to the
recording chamber (Warner Instruments, Hamden, CT,
USA) and placed on the microscope (Olympus, Tokyo,
Japan) while continuously perfused with cerebrospinal
fluid containing: 124 mM NaCl, 3 mM KCl, 1.3 mM
MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, 2.4 mM
CaCl2-2H2O, and 10 mM glucose (all from Sigma-
Aldrich). The solution was continuously aerated by O2
95 %/CO2 5 % mixed gas at RT.
A glass capillary pipette approached the cell surface.
After that, negative pressure was provided to let the pip-
ette go giga seal and whole-cell mode. Internal pipette
solution contained 115 mM K-gluconate, 10 mM KCl,
10 mM HEPES, 10 mM EGTA, 5 mM Mg-ATP, and
0.5 mM Na2+-GTP (all from Sigma-Aldrich), with pH 7.3
and 280–285 mOsm. Holding potential was −60mV. Na+
current was recorded in voltage clamp mode, and elec-
trical stimulation was given with a range from −60 mV
to +50 mV (+10 mV per each step). After that, cells
went to current clamp mode for testing action potential
generation. Cells received 15 steps of current (initial
level = 0 pA, Δ3–10 pA per step) according to their
membrane capacity. To verify that currents and spikes
were mediated by Na+ channels, tetrodotoxin (TTX)
(0.5 μM) (Sigma-Aldrich) was added to the bath for
5–10 min, and currents and spikes were retested.
Spinal cord injury and cell transplantation
All experiments were performed according to inter-
national guidelines on the ethical use of animals, and thenumber of animals used was minimized. All protocols
were approved by the Animal Care and Use Committee
of Yonsei University College of Medicine. Adult male
Imprinting Control Region (ICR) mice (35–40 g) (Orient
Bio, Gyeonggido, Korea) were used for the SCI model.
Before surgery, Cefazoline (20 mg/kg) (Yu-han, Seoul,
Korea) was injected into the animals. For anesthesia,
Zoletil 50 (30 mg/kg) (Virbac, Carros, France) and Rom-
pun (10 mg/kg) (Bayer Korea, Seoul, Korea) were
injected. After anesthesia, laminectomy was performed
at the 11th thoracic level. Compression injury (for 10
seconds) was carried out using 0.2-mm spacer self-
closing forceps at the 11th thoracic level. Cell trans-
plantation was performed 9 days after SCI. Animals were
divided into two groups: group 1 (1×PBS injection) and
group 2 (diPSC-derived NPCs, 5×105 cell injection).
Two microliters of cell suspension containing 5×105
cells was injected into the injury epicenter by using a
micro injector (KDS Scientific, Holliston, MA, USA) at-
tached to a pulled glass capillary needle (World Preci-
sion Instruments) (inner diameter of 150–200 μm) at a
rate of 1 μl/min. For immune suppression, Cyclosporine
A (10 mg/kg) (Chong Kun Dang, Seoul, Korea) was ad-
ministered to all animals until sacrifice.
Behavioral tests
To confirm whether cell transplantation improved hind-
limb functional recovery, the open-field locomotor test
was performed every week for 6 weeks by using Basso
Mouse Scale (BMS) scoring, and footprint analysis was
performed only at the final week. Briefly, both hindlimbs
were soaked in paint, and the animals walked on draw-
ing paper. Stride length, stance length, and sway length
were measured.
Immunofluorescence staining
Five weeks after cell transplantation, animals were sacri-
ficed by heart perfusion with saline and 4 % PFA (Merck,
Darmstadt, Germany)/1×PBS. Spinal cord tissue was ob-
tained and incubated in 4 % PFA for 24 h at 4 °C. After
fixation, samples were incubated in 30 % sucrose
(Sigma-Aldrich)/1×PBS solution at 4 °C. Tissues were
embedded into optimal cutting temperature compound
(Cellpath, Hemel, Hempstead, UK), incubated at −70 °C,
and cut into slices of 20-μm thickness. Immunofluores-
cence staining was performed as follows. Samples were
washed with ice-cold 1×PBS, followed by blocking with
10 % normal donkey serum (Jackson ImmunoResearch)/
1×PBS containing 0.3 % Triton X-100 (Sigma-Aldrich)
for 1 h at RT. Primary antibodies (Additional file 1) were
treated either for 1 h at RT or overnight at 4 °C. After
three washes with ice-cold 1×PBS, fluorescent dye-
conjugated secondary antibodies (Jackson ImmunoRe-
search) were treated for 1 h at RT. The samples were
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and analyzed by using an Olympus BX51 fluorescence
microscope (Olympus) and LSM 700 confocal microscope
(Zeiss, Oberkochen, Germany). The percentages of Nestin-,
beta-III tubulin (TUJ1)-, microtubule-associated protein 2
(MAP2)-, glial fibrillary acidic protein (GFAP)-, Neuron/
glia-type 2 (NG2)-, and Olig2-positive cells among total hu-
man nuclei (HNU)-positive cells within 0.3 mm2 were ex-
amined (three independent regions).
Hematoxylin-and-eosin staining
To visualize the injured spinal cord, each longitudinal
section of the spinal cord encompassing the injury site
was stained with hematoxylin and eosin (H&E). For ana-
lysis of longitudinal section, midsagittal sections of spinal
cord were used. The pixel density within 2×4 mm2 at the
injury site was quantified by using NIH Image J software
(National Institutes of Health, Bethesda, MD, USA). For
analysis of axial section, the pixel density at the lesion epi-
center and 0.8 and 0.4 mm rostral and caudal to the epi-
center, respectively, was measured by using NIH Image J
software. For H&E staining, slides were placed into
hematoxylin for 5 min and rinsed for 3 min. The pink
hematoxylin stain was converted to blue by adding Scott’s
tap water until the sections turned blue. The slides were
rinsed before being stained in eosin (1 % (wt/vol)) for
15 seconds with a subsequent wash for 3 min. The sec-
tions were then dehydrated in two washes of absolute
alcohol and in two washes of xylene for 5 min each be-
fore being mounted and covered with glass cover slips
for observation.
Statistical analysis
Student’s t tests were performed to assess differences be-
tween the two groups. One-way analysis-of-variance
tests were performed to assess difference among three
groups with the Student-Newman-Keuls test. The data
were presented as the mean ± standard error of the mean.
P values of less than 0.05 were considered statistically sig-
nificant. All data were analyzed by using MedCalc statis-
tical software (MedCalc Software, Ostend, Belgium).
Results
Isolation of disc cells for induced pluripotent stem cell
generation from a patient with spinal cord injury
In this study, we examined whether iPSCs could be gen-
erated from typically discarded disc cells isolated from
surgically removed human intervertebral discs and
whether NPCs differentiated from the diPSCs reversed
the locomotor dysfunction of an animal SCI model
(Fig. 1a). A large number of the disc-originated cells in
our culture displayed the morphology of nucleus pulpo-
sus (NP) cells, which are less elongated and more
branched than annulus fibrosus (AF) cells (Fig. 1b) [13].Consistent with this morphological observation, NP
marker genes such as aggrecan (ACAN), SRY (sex deter-
mining region Y)-box 9 (Sox9), and type II collagen
(Col2A1) were abundantly expressed in the disc cell
population (Fig. 1c) [14].
Generation and characterization of disc cell-derived induced
pluripotent stem cells from the cultured disc cells
hPSC-like colonies appeared approximately 18–20 days
after the disc cells were transduced with a mixture of
retroviral vectors expressing each of Oct4, Sox2, Klf4,
and c-Myc genes (Fig. 2a). The efficiency of iPSC forma-
tion from disc cells was approximately 0.1 %. A DNA
fingerprinting analysis confirmed that the diPSCs were
derived from the original disc cells that were used for the
iPSC generation (Additional file 3). Both immunochemis-
try and real-time RT-PCR experiments demonstrated that
the iPSC lines robustly expressed undifferentiated cell
markers Oct4, Sox2, SSEA4, Tra1-60, Tra1-80, Nanog,
DNMT3B, Zic3, and Rex1 (Fig. 2b, c). On the other hand,
low-level expression of representative markers for neu-
roectoderm (Sox1 and Pax6), mesoderm (Gata2 and
Brachyury), and endoderm (AFP and Sox17) was de-
tected (Fig. 2d). G-banding analysis indicated that there
were no gross chromosomal aberrations in the diPSCs
(Fig. 2e). Consistent with the high level of Oct4 and
Nanog gene expression, the regulatory regions of the
two genes were hypomethylated in both diPSCs and
hESCs but not in their original disc cells (Fig. 2f ). As
previously reported in many other laboratories, PCR
analysis showed that the exogenously delivered Oct4,
Sox2, Klf4, and c-Myc transgenes were turned off in
diPSCs but that their endogenous counterparts were
actively expressed (data not shown). Next, we closely
examined global gene expression patterns of diPSCs,
H9-hESCs, and disc cells. Scatter plot, correlation
matrix, hierarchical clustering, and heatmap analyses
all demonstrated that diPSCs had similar gene expres-
sion patterns to hESCs but not to their original disc
cells (Fig. 2g-j). (Additional information is shown in
more detail in Additional files 4 and 5.) All together,
these results indicated that the diPSC colonies formed
in our study displayed characteristics similar to hESCs.
Pluripotency of disc cell-derived induced pluripotent stem
cells
In spontaneous differentiation conditions, diPSCs were
shown to differentiate into derivatives of all three germ
layers, as detected by immunostaining of the following
representative germ layer markers: Nestin and beta-III
tubulin for ectoderm, smooth muscle actin (SMA) and
platelet endothelial cell adhesion molecule-1 (PECAM-1)
for mesoderm, and alpha-fetoprotein (AFP) and forkhead
box A2 (FoxA2) for endoderm (Fig. 3a). Furthermore,
Fig. 1 Experimental design and characteristics of human intervertebral disc-derived cells. a Schematic illustration of the experimental paradigm
adopted in this study. b Morphology of the cells (passage 3) derived from human intervertebral discs. c Quantitative real-time reverse transcription-
polymerase chain reaction demonstrated high expression of chondrogenic marker genes, aggrecan (ACAN), SRY (sex determining region Y)-box9
(Sox9), and type II collagen (Col2A1), in the disc cells compared with adult dermal fibroblasts, urine cells, and adipose-derived stromal cells (ADSCs). All
cell types were analyzed at passage 3. *P < 0.01 (n = 3). hDF human dermal fibroblast, iPSC induced pluripotent stem cell, NPC neural precursor cell
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plex teratomas consisting of tissues derived from all three
germ layers (Fig. 3b).
Taken together, both in vitro and in vivo results dem-
onstrated that the diPSCs retained the capability of
pluripotency.Differentiation of disc cell-derived induced pluripotent
stem cells into neural precursor cells
diPSCs were differentiated into NPCs via the previously
described EB-based method with slight modifications
(Fig. 4a) [15]. Neural rosettes were mechanically selected
and seeded as a single cell in the neural expansion
medium to culture the NPCs. The NPCs were passaged
eight times in vitro and robustly expressed NPC makers,
such as Nestin, Sox2, Pax6, and Sox1 (Fig. 4b). Semi-
quantitative RT-PCR also showed the expression of both
NPC and neural rosette markers in hPSC-derived NPCs
(H9-NPCs, diPSC1-NPCs, and diPSC2-NPCs) but not in
H9-hESCs and diPSCs (Fig. 4c).Neuronal differentiation in vitro
Next, we investigated whether the diPSC-NPCs could be
further coaxed into neurons in vitro. The neurons gener-
ated by differentiation of diPSC-NPCs displayed typical
neuronal morphology with small soma and long pro-
cesses (Fig. 4d). Twenty-one days after differentiation,
most of the neurons were expressing beta-III tubulin
(TUJ1+) (Fig. 4e, f ), microtubule-associated protein 2
(MAP2) (Fig. 4g, h), neural cell adhesion molecule
(NCAM) (Fig. 4i, j), neurofilament heavy (NF-H) (Fig. 4k),
and neuronal nuclei (NeuN) (Fig. 4l). Among them, tyro-
sine hydroxylase (TH)+ dopaminergic neurons (Fig. 4m)
and vesicular glutamate transporter 2 (vGlut2)+ gluta-
matergic neurons (Fig. 4n, o) were also detected. In
addition, diPSC-NPCs also differentiated into Olig2+oligo-
dendrocytes in serum (1 % FBS (vol/vol))-containing
medium (Fig. 4p).
The electrophysiological properties of the diPSC-
derived neurons were examined by whole-cell patch
clamp recordings. In voltage clamp mode, Na+ currents
were found in differentiated neurons (Fig. 4q). Cells were
Fig. 2 Characterization of diPSCs. a A phase-contrast image of diPSC colonies, which were generated and cultured for 15 passages. b diPSC colonies at
passage 15 were immunostained with representative pluripotency markers (Tra1-81, Tra1-60, SSEA4, Sox2, and Oct4) and were also stained for alkaline
phosphatase. c Quantitative real-time RT-PCR was performed to detect the levels of multiple undifferentiated cell markers, such as Oct4, Nanog, DNMT3B,
Zic3, and Rex1. *P < 0.01 (n = 3). d The expression levels of the representative marker genes for the ectoderm (Sox1, Pax6), mesoderm (GATA2, Brachyury),
and endoderm (AFP, Sox17) lineages were measured by quantitative real-time RT-PCR. e G-banding analysis of diPSC1 at passage 13. f Bisulfite sequencing
analysis to examine the methylation pattern of the Oct4 and Nanog promoters in H9-hESCs, disc cells, and diPSC. g, h The scatter plots compare gene
expression levels between disc cells and diPSC1 (g) and between H9-hESCs and diPSC1 (h). i Pair-wise Pearson’s correlation coefficients among gene
expression profile data for H9-hESCs, diPSC1, and disc cells are shown (top). Hierarchical clustering of the global expression profiles of H9-hESCs, diPSC1,
and disc cells is shown (bottom). j A heatmap of the expression of the disc cell and hESC-enriched genes from H9-hESCs, diPSCs (p11), and disc cells
(p3) (left). The list of disc cell and hESC-enriched genes is shown in Additional file 4. In addition, a heatmap of the expression of chondrogenic and
hESC-enriched genes is shown on the right. The list of disc cell and hESC-enriched genes is shown in Additional file 5. The genes shown in green
represent upregulation of expression, whereas the genes in red represent downregulation. diPSC disc cell-derived induced pluripotent stem cell, EB
embryoid body, hESC human embryonic stem cell, NPC neural precursor cell, RT-PCR reverse transcription-polymerase chain reaction
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Fig. 3 The differentiation of diPSCs into derivatives of the three germ layers. a diPSCs (p15) were spontaneously differentiated in vitro, and the
expression of representative markers of ectoderm (Nestin and beta-III tubulin), mesoderm (SMA and PECAM-1), and endoderm (AFP and FoxA2)
was examined. b The derivatives of the three germ layers were detected in teratomas approximately 9–10 weeks after administration of diPSCs
(2×106 cells) into nonobese diabetic/severe combined immunodeficiency mice. AFP alpha-fetoprotein, diPSC disc cell-derived induced pluripotent
stem cell, FoxA2 forkhead box A2, PECAM-1 platelet endothelial cell adhesion molecule-1, SMA smooth muscle actin
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when sequential stimulations (from −60 mV to +50 mV)
were applied. The maximum peak amplitude was −556.6
pA. For confirmation of excitability, another piece of evi-
dence indicating normal neuronal function, we used
evoked action potentials in the current clamp mode. Ac-
tion potential spikes resulted (Fig. 4r), but they appeared
only in the cells that produced Na+ currents. This result
implied that the action potentials we detected were
caused by the same Na+ channels that elicited positive
current in Fig. 4q.
To confirm that the channels that produced currents
and spikes were Na+ channels, Na+ channel antagonist
TTX was added in the bath for 5–10 min. TTX
blocked Na+ channels completely, and Na+ currents
and action potential spikes totally disappeared (Fig. 4q
and r, right panel), supporting the assertion that the
currents and spikes were mediated by Na+ channels.
diPSC-derived neurons expressed a certain level of Na+
channels and generated action potentials, indicating
that the diPSC-derived NPCs had differentiated into
mature neurons.
Functional and structural recovery in a mouse model of
spinal cord injury
To investigate whether transplantation of diPSC-NPCs
enhanced functional recovery of the hindlimbs of mice
with SCI, both the open-field locomotor test (every
week) and footprint analysis (final week) were performed.
In the open-field locomotor test, diPSC-NPC trans-
plantation significantly reversed hindlimb dysfunction
compared with the control (PBS-injected) group. The
transplanted mice frequently showed plantar stepping
with weight support (Fig. 5a). In footprint analysis,diPSC-NPC-transplanted mice had greatly improved
walking performance on plantar stepping compared
with PBS-injected mice, as judged by the significant in-
crease in the base, stance, and stride lengths (Fig. 5b, c).
These results indicated that transplantation of the diPSC-
NPCs ameliorated the hindlimb dysfunction caused by
SCI.
Next, we investigated whether transplantation of
diPSC-NPCs protected the spinal cord from damage in
the SCI mouse model. The H&E staining results showed
that significantly less damage of the spinal cord tissue
was detected in diPSC-NPC-transplanted mice than
PBS-injected control mice (Fig. 5d). Tissue sparing at
each level of the spinal cord encompassing the injury
epicenter was significantly greater in diPSC-NPC-
transplanted mice than control mice (Fig. 5e, f ), sug-
gesting that the transplanted diPSC-NPCs played a
beneficial role in structural recovery from SCI.
Differentiation of disc cell-derived induced pluripotent
stem cell-derived neural precursor cells in vivo
Five weeks after transplantation, we examined whether
the transplanted diPSC-NPCs differentiated into various
neural cell types. First, we examine the distribution of
the cells originated from the transplanted diPSC-NPCs
by using HNU antibody. A series of transverse sections
showed that the transplanted human cells were existing
from the epicenter to both rostral and caudal areas of
the spinal cord and these cells survived at least 5 weeks
after transplantation (Fig. 6a). The HNU+ cells were de-
tected across distances at least 2.4 mm along the spinal
cord with the injection site in the middle, indicating that
the transplanted diPSC-NPCs migrated actively from the
injection site (Fig. 6a). The migrated cells integrated into
Fig. 4 Generation and characterization of diPSC-NPCs. a diPSCs were coaxed into NPCs (diPSC-NPCs) via EB formation in the presence of dorsomorphin
(DM) and SB431542 (SB). EBs (top panel) and neural rosettes (middle and bottom panels) are shown. b The NPCs selected and expanded from
neural rosettes were immunostained with neural precursor markers Sox2, Nestin, Sox1, and Pax6. Bottom panels are higher-magnification
images of top panels. c RT-PCR analysis showed the expression of markers for both NPCs (Sox1 and Pax6) and neural rosettes (PLZF, DACH1,
NR2F, and PLAGL1) in NPCs derived from hESCs, diPSC1, and diPSC2. d A differential interference contrast image of neurons differentiated from
diPSC-NPCs. e, f TUJ1+ neurons at low and high magnifications, respectively. g, h MAP2+ neurons at low and high magnifications, respectively. (i and j)
NCAM+ neurons at low and high magnifications, respectively. k Dense NF+/MAP2+ axon fibers. l MAP2+/NeuN+ neurons. m TUJ1+/TH+ dopaminergic
neuron at 21 days of differentiation. n, o vGlut2+/MAP2+ glutamatergic neuron at 21 days of differentiation. The image in (o) was a high magnification
of the white box in (n). p Some diPSC-NPCs differentiated into Olig2-positive oligodendrocytes. q Na+ channel-mediated current was examined to
prove the functionality of the differentiated neurons. Na+ currents were produced in neurons. Voltage steps from −60 mV to +50 mV were applied to
the patched cells, and several positive currents were found (left, n = 3 cells/total 15 cells). By applying 0.5 μM TTX, a Na+ channel blocker, currents were
totally abolished (right). Boxes were amplified to show Na+ currents and their disappearance precisely. r Action potentials were also generated in
differentiated neurons. Narrow spikes were recorded in the cells which showed Na+ currents (left). Protocol involved sequential steps in stimulation
(right, top). Detected action potential spikes were also blocked by TTX, just as Na+ current in (q) (right, bottom). diPSC disc cell-derived induced
pluripotent stem cell, EB embryoid body, hESC human embryonic stem cell, MAP2 microtubule-associated protein 2, NCAM neural cell adhesion
molecule, NF neurofilament, NPC neural precursor cell, Olig2 oligodendrocyte lineage transcription factor 2, RT-PCR reverse transcription-polymerase chain
reaction, Sox2 SRY (sex determining region)-box 2, TH tyrosine hydroxylase, TTX tetrodotoxin, TUJ1 beta-III tubulin, vGlut2 vesicular glutamate transporter 2.
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matter (Fig. 6a, b, d).
Next, we performed double immunostaining with anti-
bodies recognizing HNU and Tuj1 to examine the per-
centage of neurons (HNU+ and Tuj1+) differentiated
from the transplanted diPSC-NPCs among total HNU+
cells. Our result showed that a significant portion of theHNU+ cells (~57 %) were also stained with Tuj1 anti-
body (Fig. 6c, d, e). In addition, we found that many
HNU+ cells (~29.5 %) were also positive for MAP2, a
marker for mature neurons (Fig. 6c, f ). We also carried
out double immunostaining for HNU and Nestin anti-
gens to measure the percentage of diPSC-NPCs which
were still remaining undifferentiated at 5 weeks after
Fig. 5 Transplantation of diPSC-NPCs enhanced the functional recovery and prevented the atrophy caused by spinal cord injury. a Basso Mouse
Scale (BMS) scores showed a significant functional recovery of hindlimbs in the diPSC-NPC-transplanted group. b Footprint analysis showed that
the diPSC-NPC-transplanted mice displayed better walking performance (plantar stepping, blue asterisk) than the control group. To obtain statistically
reliable data, we strictly followed the standard protocol of each behavioral test and tried to include many animals per group (PBS group: n = 14,
diPSC-NPC group: n = 20). c The lengths of base, stride, and stance were also significantly increased in the diPSC-NPC-transplanted group compared
with the control group. d Longitudinal sections of the spinal cord isolated from PBS (control)- or diPSC-NPC-injected mice were stained with hematoxylin
and eosin. e Tissue density of the spinal cord near the injury epicenter was measured by using National Institutes of Health Image J software. f The
cross-sectional area of the spinal cord spanning 1.6 mm in the anterior-posterior axis with the injury epicenter in the middle was examined for tissue
density. *P < 0.05. Data are presented as the mean ± standard error of the mean. diPSC disc cell-derived induced pluripotent stem cell, iPSC induced
pluripotent stem cell, NPC neural precursor cell, PBS phosphate-buffered saline, SCI spinal cord injury
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52.6 % of HNU+ cells were also positive for Nestin (Fig. 6c,
g, h). In contrast, differentiation of the transplanted
diPSC-NPCs into astrocytes (Fig. 6c, i), oligodendro-
cyte progenitor cells (Fig. 6c, j), and oligodendrocytes
(Fig. 6c, k) occurred rarely because only a few HNU
and GFAP double-positive, HNU and NG2 double-
positive, and HNU and Olig2 double-positive cells
were detected, respectively. Taken together, our results
demonstrated that transplanted diPSC-NPCs preferentiallydifferentiated into neurons in vivo, which is at least partly
responsible for the functional recovery observed after
transplantation in a mouse model of SCI.
Discussion
To date, a variety of somatic cell types have been used to
generate human iPSCs: fibroblasts [9, 16–20], circulating
T cells [9, 10, 20], cord blood stem cells [18, 21], neural
stem cells [22], molar mesenchymal stromal cells [23],
aortic smooth muscle cells [24], keratinocytes [6], and
Fig. 6 (See legend on next page.)
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Fig. 6 Immunohistological analysis at 5 weeks after transplantation of diPSC-NPCs into spinal cord-injured mice. a, b Images of horizontal sections
of the spinal cord were taken. c The percentage of each neural cell type derived from transplanted diPSC-NPCs among total human nuclei+ cells
is indicated in the graph. d, e Double immunostaining was performed with antibodies recognizing human nuclei and Tuj1. f A horizontal section
of the spinal cord was immunostained with antibodies for human nuclei and MAP2. g Double immunostaining of a horizontal section of the
spinal cord was performed with antibodies for human nuclei and Nestin. h Z-axis scanning of human nuclei and Nestin double-positive cells.
i Double immunostaining with antibodies specific for human nuclei and GFAP was performed. j Double immunostaining with antibodies specific
for human nuclei and NG2 was performed. k An example of human nuclei+ cell that was co-stained with Olig2 is shown. Data are presented as
the mean ± standard error of the mean. diPSC disc cell-derived induced pluripotent stem cell, GFAP glial fibrillary-associated protein, MAP2
microtubule-associated protein 2, NG2 neural/glial anigen-2, NPC neural precursor cell, Olig2 oligodendrocyte lineage transcription factor 2, TUJ1
beta-III tubulin
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somatic cells have their own unique characteristics with
regard to reprogramming capability, resulting in vari-
able experimental schedules and outcomes in iPSC
generation. For example, only Oct4 was required to re-
program neural stem cells into iPSCs [22], and ketati-
nocytes were approximately 100-fold more efficient at
iPSC generation than fibroblasts [6].
In most cases, patient-specific iPSCs were generated
by using fibroblasts obtained from the patient by a
punch skin biopsy because of convenience. However, this
biopsy involves a painful surgical procedure and requires
a significant amount of time to expand the cell popula-
tion sufficiently for iPSC generation. Therefore, it is of
great use to take advantage of “to-be-discarded” tissues
obtained from a surgical procedure as a source of som-
atic cells for iPSC-based, patient-specific cell therapy.
Our study proposed a paradigm of iPSC generation
using waste tissue from emergency surgery on a patient
with SCI and these iPSCs could be a potential thera-
peutic autologous stem cells for SCI.
Human intervertebral disc cells are difficult to obtain
in normal situations, and there have been no reports de-
scribing the use of disc-derived cells for iPSC generation.
However, during emergency surgery on patients with
SCI, this disc tissue is often removed as to-be-discarded
“waste” and could be a useful source for iPSC-based
autologous cell replacement therapy.
We showed that disc cells derived from the interverte-
bral disc removed from a patient with SCI abundantly
expressed disc cell marker genes such as aggrecan, Sox9,
and Col2A1. Genome-wide gene expression profile analysis
demonstrated a robust expression of chondrocyte genes,
further supporting that the cells were derived from the
intervertebral disc (Fig. 2j) (Additional file 4). The disc cells
were efficiently reprogrammed to iPSCs (named “diPSCs”)
that successfully met all the criteria of pluripotent stem
cells. Therefore, diPSCs originating from the intervertebral
disc of a patient with SCI will provide a useful therapeutic
paradigm for the treatment of SCI in the future.
The diPSCs were readily converted to NPCs by a
modified EB-mediated neural differentiation method
with dual-smad inhibition [26]. Neural rosette formationand expression of neural markers were comparable be-
tween the NPCs derived from H9-hESCs and from
diPSCs. In poly-l-ornithine/laminin-coated dishes with
neurobasal/B27-based medium, the diPSC-NPCs were
efficiently differentiated into neurons. We detected some
glutamatergic neurons expressing vGlut2 and also TH+
dopaminergic neurons (Fig. 4d). On the contrary, seroto-
nergic neurons and GABAergic neurons were hardly de-
tected (data not shown). To examine the functionality of
the neurons derived from diPSC-NPCs, we performed
whole-cell patch clamp at 3 weeks after differentiation of
NPCs. Our results showed that the differentiated neu-
rons have enough voltage-gated Na+ channels to mediate
the generation of action potentials and Na+ currents.
This result is consistent with previous studies that also
recorded Na+ currents and action potentials to identify
NPC differentiation level [27, 28].
When transplanted into the spinal cord of an SCI
mouse model, a large number of engrafted NPCs were
still alive at 5 weeks after transplantation. Intriguingly, a
significant portion of the HNU+ cells were found to be
Nestin+ NPCs (~52.6 %), TUJ1+ neurons (~57 %), and
MAP2+ neurons (~29.5 %), whereas only a small number
of the engrafted diPSC-NPCs differentiated into astro-
cytes (GFAP+), oligodendrocyte progenitor cells (NG2+),
and oligodendrocytes (Olig2+). These results are similar
to those of another group, who reported that the engraft-
ment of hiPSC-derived neurospheres produced Nestin+
NPCs (~10.7 %), TUJ1+ neurons (~49.1 %), and APC+
oligodendrocytes (~3 %) [4]. However, this group de-
tected approximately 17 % GFAP+ astrocytes, which is
significantly higher than what we observed. We specu-
late that this discrepancy might be caused by differences
in the state of engrafted cells (NPCs versus neuro-
spheres), experimental schedule (analyzed at 35 days
versus 47 days after transplantation), and the environ-
ment surrounding the engrafted cells. In fact, a signifi-
cant discrepancy has been reported in differentiation
capability between NPCs transplanted into the lesion
epicenter and NPCs engrafted onto the edge of injury
epicenter [29], and the percentage of neural cell types
has been shown to differ depending on length of time to
analysis after transplantation [4].
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despite the low capability of differentiation into oligo-
dendrocytes in our study and in reports from other
groups [4, 30]. Because remyelination of axons by oli-
godendrocytes is one of the essential processes re-
quired for behavioral recovery after SCI, it is tempting
to speculate that secreted factor(s) from the engrafted
NPCs or their differentiated derivatives may induce en-
dogenous oligodendrocyte-mediated remyelination.
Although tumorigenic potential has been regarded as
the most serious issue in ESC and iPSC transplantation
research, no tumor formation was observed in this
study. This observation is consistent with the absence of
Oct4+ cells in the diPSC1-NPC culture at passage 8
(data not shown), suggesting that diPSCs were all differ-
entiated by the neural differentiation protocol used in
this study.
Our study demonstrated that surgically removed,
to-be-discarded “waste” tissue can be reused to form
patient-specific iPSCs. Cells obtained from an emergency
surgery, especially those that are difficult to access in
normal situations, are a valuable resource for studying
cell-specific reprogramming processes, eventually deep-
ening our understanding of the cellular reprogramming
process. Furthermore, diPSCs may be used for autolo-
gous cell replacement therapy to treat patients with SCI.
In this study, iPSCs were generated from human inter-
vertebral disc tissue removed surgically to stabilize the
spine after SCI. We confirmed that chondrogenic interver-
tebral disc cells were completely changed to pluripotent
stem cells. The characteristics of the diPSCs were similar
to those of hESCs but were different from the original disc
cells. diPSC-NPCs were efficiently coaxed into mature
neurons with the typical action potential of neurons. We
confirmed in vivo that transplantation of diPSC-NPCs im-
proved the functional recovery of spinal cord-injured mice
and prevented spinal cord atrophy. A large number of
transplanted diPSC-NPCs either remained Nestin+ NPCs
or differentiated into TUJ1+ or MAP2+ neurons or both.
No tumor formation was observed in our study.
Conclusions
In this study, we demonstrated that the “to-be-discarded”
intervetebral discs removed during spinal operation could
be a rare and valuable biological source for generating
iPSC, which would be of great use to study epigenetic
memory in cellular reprogramming, and also provide an
autologous cell source for future cell replacement therapy.
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